Siemens Healthineers AG (0PMJ)

London


	Symbol		Exchange		Currency
	SHLG		Xetra		EUR	Delayed
	SHLd		BATS Europe		EUR	Delayed
	SMMNY		OTC Markets		USD	Delayed
	0PMJ		London		EUR	Real-time
	1SHL		Milan		EUR	Real-time
	SHL1y		Frankfurt		EUR	Delayed
	SHLG		TradeGate		EUR	Delayed
	SHLG		Frankfurt		EUR	Delayed
	SHLG		Dusseldorf		EUR	Delayed
	SHLG		Hamburg		EUR	Delayed
	SHLG		Vienna		EUR	Real-time

Currency in EUR

Disclaimer

52.235

-5.105(-8.91%)

Closed11/10

Fair Value

Day's Range

51.720

53.050

52 wk Range

47.810

58.060

0PMJ Income Statement

Featured here, the Income Statement (earnings report) for Siemens Healthineers AG, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

30/09

2016

30/09

2017

30/09

2018

30/09

2019

30/09

2020

30/09

2021

30/09

2022

30/09

2023

30/09

Total Revenues

14,460

17,997

21,714

21,680

Total Revenues Growth

-0.4%

+24.46%

+20.65%

-0.16%

Cost Of Revenues

8,880

11,045

13,577

13,971

Gross Profit

5,580

6,952

8,137

7,709

Gross Profit Growth

-3.73%

+24.59%

+17.05%

-5.26%

Gross Profit Margin %

38.59%

38.63%

37.47%

35.56%

Other Operating Expenses, Total

3,636

4,384

5,213

5,576

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+3.89%	+20.57%	+18.91%	+6.96%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,342	1,546	1,785	1,866
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,279	2,817	3,408	3,607
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	15	21	20	103

Operating Income

1,944

2,568

2,924

2,133

Operating Income Growth

-15.33%

+32.1%

+13.86%

-27.05%

EBIT Margin %

13.44%

14.27%

13.47%

9.84%

Net Interest Expenses

-23

-50

-70

-211

Net Interest Expenses Growth

+72.94%

-117.39%

-40%

-201.43%

Interest Expense, Total

-76

-83

-118

-296

Interest And Investment Income

53

33

48

85

Other Non Operating Expenses, Total

0

-115

-53

6

EBT, Excl. Unusual Items

1,921

2,403

2,801

1,928

Gain (Loss) On Sale Of Assets

-

-

-

-

Other Unusual Items, Total

34

-

-

-

EBT, Incl. Unusual Items

1,955

2,403

2,801

1,928

EBT, Incl. Unusual Items Growth

-10.81%

+22.92%

+16.56%

-31.17%

EBT, Incl. Unusual Items Margin

13.52%

13.35%

12.9%

8.89%

Income Tax Expense

532

658

746

403

Net Income to Company

1,423

1,745

2,055

1,525

Minority Interest

-12

-18

-17

-16

Net Income

1,411

1,727

2,038

1,509

Net Income Growth

-9.96%

+22.4%

+18.01%

-25.96%

Net Income Margin %

9.76%

9.6%

9.39%

6.96%

Preferred Dividend and Other Adjustments

-

-

-

-

Net Income to Common Excl. Extra Items

1,411

1,727

2,038

1,509

Basic EPS - Continuing Operations

1.41

1.57

1.82

1.35

Basic EPS - Continuing Operations Growth

-10.19%

+11.51%

+15.58%

-25.74%

Diluted EPS - Continuing Operations

1.4

1.57

1.81

1.34

Diluted EPS - Continuing Operations Growth

-10.72%

+12.14%

+15.29%

-25.97%

Basic Weighted Average Shares Outstanding

1,001.86

1,099.69

1,122.79

1,119.47

Diluted Weighted Average Shares Outstanding

1,004.07

1,103.6

1,127.75

1,123.55

Dividend Per Share

0.8

0.85

0.95

0.95

Dividend Per Share Growth

0%

+6.25%

+11.76%

0%

EBITDA

2,502

3,307

3,941

3,211

EBITDA Growth

-10.8%

+32.17%

+19.17%

-18.52%

EBITDA Margin %

17.3%

18.38%

18.15%

14.81%

EBIT